The big picture: U.S. opioid crisis has no end in sight

Illustration: Sarah Grillo/Axios 

The House is voting on dozens of bills to address rampant opioid addiction— an issue that unifies lawmakers and voters like no other, and is often deeply personal.

The big picture: This epidemic is touching more and more of us: More than 40% of millennials personally know someone who has dealt with an opioid addiction, according to an NBC News/GenForward poll out Friday.

  • But Washington is still playing catch-up. Many of the changes being made by Congress and the administration are meaningful, but experts say there’s still far more to be done, especially on treating addiction.

What Congress is doing: Funding for the epidemic has drastically increased in recent years — the most recent spending bill dedicated about $4 billion to the crisis. But there are other policy changes are underway, including those being voted on in the House this month:

  • One would get rid of a ban on federal Medicaid funding for mental health treatment facilities with more than 16 beds. That might be the most significant change.
  • Some bills also create new prescription opioid policies,like requiring the Food and Drug Administration to work with drug companies on ways to return or destroy unused opioids.
  • Another proposal would allow more providers to use buprenorphine, a type of medication-assisted therapy.
  • To crack down on imported fentanyl, the House passed a bill that gives the FDA more authority to seize fentanyl arriving through international mail.

What Congress isn’t doing: Experts say states need more money over a longer period, and that the country's overall treatment infrastructure needs a significant upgrade, as most of the country is ill-equipped to deal with the epidemic.

Go deeper:

What's next

New York Times endorses Elizabeth Warren and Amy Klobuchar for president

Democratic presidential candidates Sens. Elizabeth Warrenand Sen. Amy Klobuchar at the December 2020 debatein Los Angeles. Photo: Justin Sullivan/Getty Images

The New York Times editorial board has endorsed Sens. Elizabeth Warren and Amy Klobuchar for president, in a decision announced on national television Sunday night.

Why it matters: The board writes in its editorial that its decision to endorse two candidates is a major break with convention that's intended to address the "realist" and "radical" models being presented to voters by the 2020 Democratic field.

Go deeperArrow58 mins ago - Media

What's next in the impeachment witness battle

Sens. Susan Collins (R-Maine) and Lisa Murkowski (R-Alaska). Photo: Tom Williams/CQ-Roll Call, Inc via Getty Images

Senators will almost certainly get to vote on whether or not to call impeachment witnesses. The resolution laying out the rules of the trial, which will be presented Tuesday, is expected to mandate that senators can take up-or-down votes on calling for witnesses and documents.

Yes, but: Those votes won't come until the House impeachment managers and President Trump's defense team deliver their opening arguments and field Senators' questions.

Inside Trump's impeachment strategy: The national security card

White House counsel Pat Cipollone and acting Chief of Staff Mick Mulvaney. Photo: Jabin Botsford/The Washington Post via Getty Images

Trump officials say they feel especially bullish about one key argument against calling additional impeachment witnesses: It could compromise America's national security.

The big picture: People close to the president say their most compelling argument to persuade nervous Republican senators to vote against calling new witnesses is the claim that they're protecting national security.